Status:

COMPLETED

Fever and Wheezing Events in Children After US Influenza Vaccines Using Text Messaging

Lead Sponsor:

Columbia University

Collaborating Sponsors:

Centers for Disease Control and Prevention

Boston Medical Center

Conditions:

Fever

Wheezing

Eligibility:

All Genders

2-11 years

Phase:

NA

Brief Summary

Children 2-11 years of age who are given the influenza vaccine (inactivated influenza (IIV) or live attenuated influenza vaccine (LAIV)) as part of their routine care can enroll in this study if their...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • are 2 through 11years of age,
  • have a visit at a study site anytime during the study period,
  • receive first dose or second dose of LAIV4 or IIV in the season,
  • the parent has a cell phone with text messaging capabilities, and
  • the parent and child \> 7 years of age speaks English or Spanish at the Columbia sites or English at the Boston site.
  • Exclusion criteria:
  • presence of fever ≥100.4 at time of vaccination,
  • administration of any antipyretic in the 6-hour period prior to vaccination,
  • stated intent, at time of vaccination, to use prophylactic antipyretics before the development of a fever,
  • parent only speaks a language other than English or Spanish at the Columbia sites or English at the Boston site.
  • enrollee is a child \>7 years of age who only speaks a language other than English or Spanish at the Columbia sites or English at the Boston site.
  • parent's inability to read and send text messages,
  • sibling already enrolled this season (OR cell phone # already used for another child)
  • chronic medical condition considered by ACIP to be a precaution or contraindication for LAIV1 (except for asthma),
  • current asthma exacerbation, or exacerbation in the last 2 weeks
  • use of oral or other systemic steroid within the last 2 weeks

Exclusion

    Key Trial Info

    Start Date :

    December 1 2014

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    May 1 2016

    Estimated Enrollment :

    266 Patients enrolled

    Trial Details

    Trial ID

    NCT02295007

    Start Date

    December 1 2014

    End Date

    May 1 2016

    Last Update

    May 12 2016

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Centers for Disease Control and Prevention

    Atlanta, Georgia, United States, 30333

    2

    Boston Medical Center

    Boston, Massachusetts, United States

    3

    Columbia University

    New York, New York, United States, 10032